Topaz Kirlew Named Chief Regulatory Officer at Integra LifeSciences

Integra LifeSciences Holdings Corporation has appointed Topaz Kirlew as corporate vice president and chief regulatory officer. She will lead the company’s global regulatory affairs organization and oversee regulatory strategy, compliance, submissions, and transformation initiatives worldwide.

Kirlew served as the interim regulatory leader for the company over the past several months. In her interim capacity, she supervised regulatory compliance, managed active submissions, and led risk mitigation efforts across the organization.

“Topaz brings deep regulatory experience, sound judgment, and a practical approach to helping the business move forward the right way,” Integra LifeSciences Chairman/CEO Stuart Essig said. “She has earned the confidence of the leadership team, and I am pleased to have her in this role as we continue to strengthen our regulatory capabilities and advance our mission of restoring patients’ lives.”

Since joining Integra in 2021, Kirlew has played a key role in building the company’s regulatory capabilities and advancing key business priorities. She brings more than 35 years of healthcare and medical technology industry experience spanning regulatory affairs, quality, operations, and clinical functions.

Before joining Integra, Kirlew held positions of increasing responsibility at several healthcare and medical technology organizations, including Danaher Corporation, Apyx Medical, Bio-Tissue, and the University of Miami’s Diabetes Research Institute. She began her career as a clinical laboratory scientist, serving at various healthcare institutions, including the National Institutes of Health, Georgetown University Hospital, and the University of Maryland Medical Center.

Kirlew earned a bachelor’s degree in clinical laboratory science from Florida International University and holds a master’s degree and a doctorate in business administration from Nova Southeastern University’s School of Business and Entrepreneurship.

Integra LifeSciences is a global medical technology firm advancing care through innovations in neurosurgery and tissue reconstruction, specialized fields that demand expertise and precision. The company’s highly differentiated technologies are used to deliver transformative care.